Modern treatment for nasopharyngeal carcinoma: current status and prospects

201156 citationsReview

Authors

Sylvie Rottey · Belgian Society of Medical Oncology

Philippe Deron · Ghent University Hospital

Simon Van Belle · Belgian Society of Medical Oncology

Abstract

Epstein-Barr virus DNA has a potential as a risk stratification marker. Intensity-modulated radiotherapy is standard treatment and adaptive radiotherapy with re-planning has to be considered. Uncertainties on adjuvant/neoadjuvant chemotherapy should be addressed in well designed randomized trials. Currently, the role of targeted agents is not well defined.

Topics & Keywords

Head and Neck Cancer Studies Viral-associated cancers and disorders Lung Cancer Research Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Current Opinion in Oncology

Volume 23, Issue 3, pp. 254-258

DOI: 10.1097/cco.0b013e328344f527

Field-Weighted Citation Impact: 4.72